Rwanda is looking to attract at least Rwf19 billion (about $17.5 million) investment in the production of cannabis, also known as a high-value therapeutic crop, The New Times has learnt.
The development was recently ranked among the country’s top 100 investment opportunities, during the Invest Rwanda Forum held last week.
ALSO READ: Under what circumstances can medical marijuana be prescribed?
According to the Rwanda Development Board (RDB), global cannabis production is projected to grow from the current $28.3 billion raked in 2021, to $197.7 billion in 2028 at a compound annual growth rate of 32 per cent.
"This represents a significant opportunity that can be further explored by Rwanda,” reads part of RDB’s document.
Key products with potential medical cannabis, RDB added, include industrial hemp, edible products as well as cannabis oils.
Two years ago, Rwanda laid out plans to kick-start growing and exporting cannabis and its products.
The development, among others, provided a framework for responsible and secure cultivation, processing, distribution and use of cannabis in the country.
ALSO READ: 10 things to know after Rwanda gives the green light for medical marijuana
A year later, the country announced that it had designated 134 hectares to cannabis production, in the build-up to delivering the plant to the local market.
The New Times learnt that works are ongoing to see that the site is developed, and that about six companies, up from five last year, have shown strong interest.
"One of them is in advanced stages and we could soon have something on the ground,” a reliable source told The New Times.
When pressed for details, the source declined to provide further information but pointed out that no licenses have been given out yet.
"If you get licensed to grow these therapeutic crops in Rwanda, you will be required to have in place a very strong security programme that has to be approved by our security organs, and that security programme is going to be highly implemented,” Clare Akamanzi, the Chief Executive at RDB, said in an earlier interview.
"There will be no way that it (cannabis) can leak out of the farm to go to the domestic market or to the wrong users. The crops will be in a designated place, and there will be very strong measures, whether it is CCTV cameras, watch towers, street lights, and human security. So it is going to be extremely secure,” she added.
Cannabis produced in Rwanda will be exclusively for export purposes. The biggest markets being looked at are the US, Canada, and Europe.
During the same interview, Akamanzi insisted that the main reason for the country’s move to start producing therapeutic crops is to contribute to health and medicinal research around the world and improve the lives of people.
However, she also highlighted that there is a great economic benefit to Rwanda since such crops are highly profitable. Here, she said a hectare of these crops can bring in up to $10 million, an amount that is way higher than the $300,000 that can come out of a hectare of flowers.
The companies that have so far applied for production licenses, according to RDB, have been from a broad range of geographies, including consortiums with local companies as well.
In its regulatory work, RDB will be working alongside several government institutions including the Rwanda Inspectorate, Competition and Consumer Protection Authority, the Rwanda Food and Drug Authority, and the Rwanda National Police to ensure firm implementation of safety guidelines during the production of cannabis.
The consumption of cannabis products for recreational purposes remains illegal in Rwanda. The country maintains harsh penalties for the illegal production, distribution, and consumption of cannabis.
The law governing narcotic drugs, psychotropic substances, and precursors, imposes fines of between Rwf500, 000 and Rwf5 million and prison terms of between three to five years for anyone found illegally using marijuana.